| Literature DB >> 27893783 |
Ezgi Eyluel Bankoglu1, Oliver Tschopp2, Johannes Schmitt3, Philipp Burkard1, Daniel Jahn3, Andreas Geier2,3, Helga Stopper1.
Abstract
Type 2 diabetes (T2DM) and obesity are frequently associated with non-alcoholic fatty liver disease (NAFLD) and with an elevated cancer incidence. The molecular mechanisms of carcinogenesis in this context are only partially understood. High blood insulin levels are typical in early T2DM and excessive insulin can cause elevated reactive oxygen species (ROS) production and genomic instability. ROS are important for various cellular functions in signaling and host defense. However, elevated ROS formation is thought to be involved in cancer induction. In the molecular events from insulin receptor binding to genomic damage, some signaling steps have been identified, pointing at the PI3K/AKT pathway. For further elucidation Phosphatase and Tensin homolog (Pten), a tumour suppressor phosphatase that plays a role in insulin signaling by negative regulation of PI3K/AKT and its downstream targets, was investigated here. Dihydroethidium (DHE) staining was used to detect ROS formation in immortalized human hepatocytes. Comet assay and micronucleus test were performed to investigate genomic damage in vitro. In liver samples, DHE staining and western blot detection of HSP70 and HO-1 were performed to evaluate oxidative stress response. DNA double strand breaks (DSBs) were detected by immunohistostaining. Inhibition of PTEN with the pharmacologic inhibitor VO-OHpic resulted in increased ROS production and genomic damage in a liver cell line. Knockdown of Pten in a mouse model yielded increased oxidative stress levels, detected by ROS levels and expression of the two stress-proteins HSP70 and HO-1 and elevated genomic damage in the liver, which was significant in mice fed with a high fat diet. We conclude that PTEN is involved in oxidative stress and genomic damage induction in vitro and that this may also explain the in vivo observations. This further supports the hypothesis that the PI3K/AKT pathway is responsible for damaging effects of high levels of insulin.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27893783 PMCID: PMC5125655 DOI: 10.1371/journal.pone.0166956
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Viability of cells after treatment with insulin and the PTEN inhibitor VO-OHpic.
| Treatment Groups | Viability (%) |
|---|---|
| 93.88 ± 1.60 | |
| 96.88 ± 0.83 | |
| 97.38 ± 0.75 | |
| 96.13 ± 1.53 | |
| 96.88 ± 1.39 | |
| 94.38 ± 1.13 |
Date are shown as mean ± SEM from 4 independent experiments.
Apoptotic and mitotic cells after treatment with insulin and the Pten-inhibitor VO-OHpic.
| Treatment Groups | Apoptosis | Mitosis |
|---|---|---|
| 1 ± 0.23 | 1 ± 0.1 | |
| 0.83 ± 0.15 | 1.07 ± 0.19 | |
| 0.56 ± 0.2 | 1.29 ± 0.19 | |
| 1.14 ± 0.18 | 1.18 ± 0.14 | |
| 1.11 ± 0.19 | 1.05 ± 0.17 | |
| 1.14 ± 0.41 | 1.18 ± 0.21 |
Data are shown as mean fold change compared to control (± SEM) and are calculated from evaluated numbers/1000 cells from 4 independent experiments.
Cytokinesis block proliferation index (CBPI) after treatment with insulin and PTEN inhibitor VO-OHpic.
| Treatment Groups | CBPI |
|---|---|
| 1.95±0.008 | |
| 1.95±0.004 | |
| 1.94±0.011 | |
| 1.96±0.004 | |
| 1.97±0.005 | |
| 1.97±0.006 |
Date are shown as mean ± SEM from 4 independent experiments.